Celldex Therapeutics Inc. | Key People and Executives
Anthony S. Marucci
President, Chief Executive Officer & Director
Herbert J. Conrad
Director
Keith L. Brownlie
Independent Director
James J. Marino
Independent Director
Karen Lipton Shoos
Independent Director
Harry H. Penner
Independent Director
Anthony S. Marucci
President, Chief Executive Officer & Director
Sam Martin
Chief Financial Officer, Secretary & Senior VP
Tibor Keler
Chief Scientific Officer & Executive VP
Sarah Boylan Cavanaugh
Senior VP-Corporate Affairs & Administration
Christopher Turner
Vice President-Clinical Science
Elizabeth Crowley
Chief Product Development Officer & SVP
Ronald A. Pepin
Chief Business Officer & Senior Vice President
Richard Wright
Chief Commercial Officer & Senior Vice President
Herbert J. Conrad
Director
Margo Heath Chiozzi
Senior Vice President-Regulatory Affairs
Keith L. Brownlie
Independent Director
James J. Marino
Independent Director
Karen Lipton Shoos
Independent Director
Harry H. Penner
Independent Director
| Address |
Perryville III Building
Hampton New Jersey 08827
United States
|
|
Employees
|
- |
| Website |
http://www.celldex.com |
| Updated |
09/14/2018 |
| Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. |
